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Abstract 
Obesity is epidemic that affects more than a third of the U.S. population. Additionally, 
the influenza virus is an infectious disease that affects millions of people and claims a quarter to 
half a million lives each year. The few studies that have been conducted on these two factors and 
their effect on immune response have found that obese influenza-infected mice had suppressed 
immune function in combatting the influenza infection as well as reduced expression of 
proinflammatory cytokines and decreased NK cell cytotoxicity. In this study, we expand on this 
topic and explore the effects of NK cell cytotoxicity with diet-induced weight change in 
influenza-infected mice. One of the goals of this study is to determine if beneficial weight 
change from a metabolically obese mouse to lean plays a significant role in restoring NK cell 
function. Upon analyzing the data, we found that weight change did not play a significant role 
affecting NK cell cytotoxicity. Furthermore, we found that the original weight status of the 
mouse had similar NK cell function and so mice that were originally lean, regardless of if they 
underwent weight change, had a significantly greater NK cell cytotoxicity than if the mouse was 
originally obese. I believe that these studies are relevant to global public health and preventative 
medicine because if we are able to determine how weight change effects the immune function in 
influenza-infected models, we will be better able to understand how to help certain individuals 
based on their weight status.  
Introduction 
Obesity and the Immune System 
 Beginning in the late twentieth century, the scientific community began to acknowledge 
obesity as a growing epidemic and a cause for many health risks such as cardiovascular disease, 
diabetes, and cancer. Obesity trends have been growing globally as well as nationally and in the 
last decade alone the prevalence of adult obesity has increased 5.5% in the United States. The 
most recent (2011-2014) figures from the CDC indicate that 36.5% of U.S. adults and 17.2% of 
U.S. children are obese (1). More importantly obesity has shown to result in altered immune 
response leading to increased susceptibility to bacterial infection, chronic increases in pro-
inflammatory response, and even increased vulnerability to viral infections (2). With a little over 
a third of the population dealing with the disease and its many health risk factors, obesity 
prevention and treatment plays a crucial role in the sustainability of a healthy population.  
 The immune system plays an integral part in humans as the primary protector of the body 
against foreign pathogens while also utilizing biological mechanisms for self-identification and 
maintenance. The immune system is divided into two classes: innate (non-specific) and acquired 
(specific) immunity. The innate immune system consists of several components such as physical 
barriers and mucous membranes, antimicrobial substances, phagocytes such as neutrophils and 
macrophages, and other leukocytes such as natural killer (NK) cells (3).  The innate immune 
system is regarded as the general response by the body and uses germline-encoded pattern-
recognition receptors (PRRs) for microbial recognition. PRRs can bind to microbial components 
known as pathogen-associate molecular patterns (PAMPs), essential for the survival of the 
microorganism, and allow for detection of the pathogen. PPRs are non-specific and independent 
of immunologic memory making the immune cells that utilize them a component of the innate 
immune system (4). The acquired (or adaptive) immune system is primarily characterized by its 
utilization of memory and past interactions to deliver immune response. This system recognizes 
foreign antigens projected on bacteria and virus-infected host cells and generates humoral and 
cell-mediated responses that are tailored to specifically destroy the pathogens carrying specific 
antigens. These two responses also develop an “immunological memory” in order to handle 
subsequent attacks by the same pathogens (3). 
Natural Killer Cells 
 Natural killer cells, also known as NK cells, are large, granular lymphocytes belonging to 
the innate immune system. NK cells are primarily developed in the bone marrow, but are found 
in the lungs, liver, lymph, and spleen, with the spleen being the target tissue for this study (5). 
NK cells serve several important functions most importantly in response to viral infections and 
tumor formations. In terms of viral infections, such as influenza, NK cells are recruited through 
two mechanisms. Either they are stimulated by direct engagement on their activating receptors 
by viral ligands or by the activation of chemokines and cytokines, such as interferon gamma 
(IFN-γ) and TNF-α, produced by other components of the immune system. These complex 
receptor interactions elude to the point that NK cells have more role in adaptive immunity than 
previously thought and why more research is being done about the specific roles NK cells play in 
this alternative branch of the immune system (5,6). 
 NK cells most prominent role is in the detection and destruction of virus-infected and 
cancer cells through their cytotoxic ability. NK cell cytotoxicity is a tightly regulated process and 
dictated by an array of receptors and signals that determine whether or not a cell in the body 
should be targeted by NK cells. The primary and most well understood mechanism is through a 
hypothesis known as the “missing self” hypothesis. Primarily all nucleated cells in the body have 
a major histocompatibility complex class I or MHC-I. MHC-I is present on the cell surface and 
displays intracellular peptides that the cells use for normal protein functions. This represents a 
display of normal function or “self” for a cell (5). Virus-infected cells and cancer cells can have a 
down regulation of MHC-I because it is thought that in order to avoid other immune responses 
they decrease MHC-I translation. On a side note, NK cells have two classes of surface receptors, 
activating and inhibitory. It is the inhibitory receptors on the cell surfaces of NK cells which 
sense a down regulation of the MHC-I molecules. This mechanism is the indicator for NK cells 
that the cell is not functioning normally and has lost the sense of “self”. The second mechanism 
mentioned earlier is through the use of activating ligands on the cell surfaces of virus-infected 
and cancer cells. One example is that NK cells that carry a receptor such as Ly94H which 
recognizes ligands produced by virally-infected cells like m157 (6-8). When the NK cell 
encounters the correct ligand for its activating receptor it will activate its cytotoxic ability and be 
able to destroy the cell. NK cells exocytose intracellular granules such as perforin and other 
granzymes to create pores in the target cell membrane and induce apoptosis (9). Because there is 
an array of receptor and ligand interactions, NK cell mechanisms are still studied extensively 
seeing as how they work synergistically with other aspects of the immune system to recognize 
and ultimately destroy virus-infected and tumor cells.  
Influenza and Obesity’s Effect on NK Cells 
 Influenza is an airborne infectious disease caused by the influenza virus. Every year, 
there is an influenza outbreak affecting three to five millions of people and resulting in up to half 
a million deaths worldwide (10). The influenza virus is classified as an RNA virus due to its 
genomic make-up and has three distinct classes: Influenza A, B, and C. Additionally, with 
obesity dramatically on the rise and affecting a large portion of the population, various studies 
have been conducted exploring the effect obesity has on one’s susceptibility to viral infections 
such as the influenza virus (11). For example, following the H1N1 pandemic in 2009 the 
California Department of Public Health found that obese adults were more hospitalized due to 
H1N1 and that extreme obesity was associated with increased odds of death by the virus (12). 
 Influenza’s effects have also been studied with the immune system, specifically NK cells. 
Following an infection with the influenza virus, NK cells are recruited to lung and other infected 
tissues with various signals such as interferon gamma. These NK cells function to destroy the 
influenza-infected cells as well as help in adaptive immunity to the influenza virus. Various 
experiments, human and murine, have looked at NK cell function with influenza virus. One 
murine study found that certain receptors NKp46/NCR1 were essential in influenza response by 
NK cells. Knockout mice without these NK receptors had increased viral titers compared to the 
normal wild-type mice. Additionally, a human found during the pandemic of H1N1 that 
individuals had decreased numbers of peripheral blood NK cells compared to their healthy 
counterparts (8). However, much more research needs to be done to determine how influenza and 
obesity play a role in NK cell function. 
 The central literature that this study is developed from explores the immune response of 
diet-induced obese mice compared to normal lean mice. The study found that NK cell 
cytotoxicity and enumeration was significantly reduced in the influenza-infected mice in the lung 
and spleen. In this study we wanted to expand on this association and explore the effects of 
weight change on NK cell cytotoxicity. By creating two additional groups of mice, lean-to-obese 
and obese-to-lean, we would be able to potentially see if weight change could restore NK 
function (2).  
Methods 
Mice Growth and Diet 
 The mice used for the study were C57BL/6J mice obtained from Jackson Labs. Their 
genetic background makes them susceptible to diet induced obesity making them a good model 
for this study. The mice are obtained at 6 weeks of age and are acclimated for one week at the 
UNC School of Medicine Animal Colony. The mice were then randomly placed into two groups 
to induce the initial weight status. One group was fed normal chow (low fat) to maintain a 
metabolically lean weight status while the second group was put on a high fat diet to induce 
obesity. Additionally, the mice were also infected with influenza in the first 22 weeks to create 
an influenza-infected mouse model for this study. At the end of 22 weeks, both groups were 
randomly divided into two additional groups. Half would remain on the same diet and half would 
switch to the alternate (low or high fat) diet to induce weight change. After 15 weeks on the 
weight altering diet, the mice were now in four distinct groups: always lean, always obese, lean-
to-obese, and obese-to-lean. The mice were then euthanized and spleens were extracted. Jenny 
Rebeles of the Beck lab was the primary animal handler and caretaker for the mouse study 
population. 
YAC-1 Cell Growth and Maintenance 
 To perform the NK cytotoxicity assay, target cells are required to interact with the spleen 
cells of the mice. The cells obtained as the target for the spleen NK cells were YAC-1 cancer cell 
line which is commonly used for NK cell studies. These cells were cultured in 75 cm2 culture 
flasks containing 7.5 mL of RPMI 1640 (ThermoFisher) with 10% fetal bovine serum and 1% 
Pen-strep and stored in an incubator at 37°C with 5% CO2. The cells were split in their 
logarithmic growth phase which peaked at 1 to 2 million cells per mL as this was the optimal 
growth volume before deterioration of the media and overcrowding in the cell plates. The YAC-
1 cells were maintained throughout a six-month period from June 2016 to December 2016. The 
cells were split regularly during this time period and if viability was down, there was a batch of 
frozen YAC-1 cells stored in liquid nitrogen. Prior to being used in the cytotoxicity assay, the 
YAC-1 cells were split 24 hours before to ensure that they were in an upward growth phase and 
not too old. Splitting these cells the day before allowed them to be fresh and ensure the greatest 
viability for the experimental assay. 
Spleen Extraction and Cell Enumeration 
 To obtain the spleenocytes to use for the cytotoxicity assay, spleens were extracted from 
the mice the same day they were euthanized. The entire spleen was removed and placed in a 10% 
FBS RPMI media with Pen-Strep on ice. Any fat tissue or adiposity was separated from the 
spleen tissue and discarded. The end of a 5 mL syringe was used to crush and dissolve the spleen 
tissue in the spleen media. The aim was to obtain a single cell suspension of the spleen media, 
therefore this was done thoroughly until there were no visible tissue clumps remaining. The 
solution was then run through a 40 μm nylon mesh cell strainer to separate the spleen tissue and 
have single cell spleen suspension in the spleen media. This solution was then centrifuged at 300 
x G for 8 minutes at 8° C. One mL of ammonium-Chloride-Potassium (ACK) lysis buffer was 
added for 1 minute at room temperature to lyse red blood cells from the spleen solution which 
would interfere with spleen cell enumeration. Visible cell debris would form after this step and 
would be removed by pipette. This step was repeated 2 to 3 times with the ACK lysis buffer until 
there was no visible layer of blood after centrifuging. The spleen pellet was then suspended in 1 
milliliter of spleen media and placed on ice until cell counting. 
 At this stage in the procedure the YAC-1 cells were also prepped so that both 
spleenocytes and YAC-1 cells could be counted using a hemocytometer at the same time. For the 
setup of the cytotoxicity assay, discussed in detail below, there were to be four sets of spleen-to-
cancer cell ratios for each mouse spleen. In essence, there would be a ratio of 100:1, 50:1, 25:1, 
and 12.5:1 of spleen cells to cancer cells. Prior to running the experiment, optimization protocols 
were run to determine the optimal number of target cells (YAC-1 cancer cells) to use. In the 
October 4, 2016 experiment 10,000 YAC-1 cells per well were used whereas in the December 
20, 2016 experiment it was 40,000 YAC-1 cells per well. For spleenocytes the ratios were 
determined based off the YAC-1 target cells in the respective ratios listed above. These cells 
were counted by staining with Trypan Blue at a 1:1 ratio of cells to Trypan Blue. The cells per 
mL were calculated accordingly and the cell solutions, spleenocyte and YAC-1 cells, were 
diluted to equal their target cells per mL. 
Cytotoxicity Assay 
 The assay used in this study was the CytoTox 96® Non-Radioactive Cytotoxicity Assay 
developed by Promega (13). This is an alternative and safer procedure compared to the 
previously used radioactive Chromium release cytotoxicity assays. The CytoTox 96 assay works 
by measuring lactate dehydrogenase (LDH) which is released upon cell death. LDH is an 
enzyme that converts lactate to pyruvate and is present is most cells including the YAC-1 tumor 
cells. The reagent solution, which is a part of the assay kit, contains tetrazolium salt or 
iodonitrotetrazolium violet (INT) which reacts through the released LDH to form a red formazan 
product. The amount of formazan red created is proportional to the amount of LDH released and 
is in turn proportional to the amount of cells that were lysed or killed (13). The absorbance of the 
wavelengths from each well are then read using a standard plate reader and these absorbance 
values are calculated with various controls to determine the relative cell death in each well. In 
terms of the study, the NK cells from the spleenocytes should be interacting with the YAC-1 
tumor cells causing them to lyse and die. The conversion of INT to formazan product should 
then only be occurring due to NK cell cytotoxicity of YAC-1 cells which are releasing LDH 
upon death. The proportions calculated from the absorbance values should then give us the 
percent cytotoxicity of their NK cells that each mouse in the four diet groups had. This would 
then allow us to compare cytotoxicites between the four groups and determine NK cell 
effectiveness. 
 The assay plates used were standard 96 V-bottom cell plates. The plates were all setup 
with either control or experimental wells in either triplicates or quadruplicates. The first set of 
wells were the experimental wells. These contained 100 uL of the YAC-1 target cells, 100 uL 
spleenocytes at the four ratios 100:1, 50:1, 25:1, and 12.5:1 of spleen-to-cancer cells (in the 
12/20/16 experiment 100:1 ratio was removed and 6.25:1 ratio was added). Adjacent to each of 
these wells was the effector spontaneous LDH release wells which contained 100 uL of culture 
media, 100 uL of spleenocytes in order to determine how much LDH is released naturally from 
the spleenocytes themselves through leaking, apoptosis, or etc. Next a target cell (YAC-1) 
spontaneous and maximum LDH wells were prepared with 100 uL of culture media in the former 
and 100 uL of a lysis solution in the latter. Finally, culture background and volume correction 
control wells were setup with 100 uL of culture media with 100 uL spleenocytes and 100 uL 
culture media, 100 uL Spleen Media, and 20 uL lysis solution, respectively (13). 
Figure 1. Example setup of the cell plate with all six well types described above. Each 96 
well plate can hold two mouse spleen samples. 
Running the Cytotoxicity Assay 
 Once plate setup was completed, the plate was placed in an incubator (37°C, 5% CO2) for 
four hours to allow time for the NK cells and target YAC-1 tumor cells to interact. In the 
12/20/16 trial, the incubation time was increased to six hours to allow for more time the NK cells 
and tumor cells to bind. Forty-five minutes before the incubation time was finished, the lysis 
solution was added to all the maximum release and volume correction control wells. After the 
incubation time was complete, all the plates were spun in a centrifuge for 250 x G for 4 minutes. 
Then, 50 uL aliquots from all the wells were transferred to a 96 well flat-bottom plate where 50 
uL of the CytoTox 96 Regeant was added to all the wells. This reagent contained the enzyme that 
would interact with LDH and turn red proportionately to the amount of LDH released. After a 
30-minute rest period with the plate placed in room temperature under no light conditions, 50 uL 
of Stop solution was added to each well to end the INT to red formazan reaction. Finally, the 
plate was placed in a plate reader and the absorbance values were recorded at 490 nm.  
Calculations 
 After absorbance values were recorded, the percent cytotoxicity for each mouse was 
calculated incorporating the background and spontaneous release wells using the following 
formula (13).  
% 𝐶𝑦𝑡𝑜𝑡𝑜𝑥𝑖𝑐𝑖𝑡𝑦 =
𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 − 𝐸𝑓𝑓𝑒𝑐𝑡𝑜𝑟 𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 − 𝑇𝑎𝑟𝑔𝑒𝑡 𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠
𝑇𝑎𝑟𝑔𝑒𝑡 𝑀𝑎𝑥𝑖𝑚𝑢𝑚 − 𝑇𝑎𝑟𝑔𝑒𝑡 𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠
∗ 100 
Equation 1. Formula used to calculate percent cytotoxicity for each mouse at the four 
effector-to-target cell ratios. 
Statistical Design 
 An ANOVA test was run for the four mice groups using SAS statistical software. A t-test 
was run after combining the groups into two groups to determine significance. Differences were 
considered significant at a P < 0.05. 
Results 
 The data obtained for the study primarily originates from two trials, a twenty mouse trial 
on October 4, 2016 and a three mice trial on December 20, 2016, with slight variations from each 
other in procedure outlined earlier. The percent cytotoxicity for each mouse were calculated with 
respect to their group type and effector-to-target cell ratios using the absorbance values. The 
tables for the two trials are shown below. 
Table 1. Mouse data from trial 1 with mouse IDs, weight type, and percent cytotoxicity at 
each of the four effector-to-target cell ratios obtained on October 4, 2016 
 % Cytotoxicity 
Date Mouse # Type 100:1 50:1 25:1 12.5:1 
10/4/2016 21 Lean 5.66 12.45 18.28 2.87 
10/4/2016 22 Lean 12.36 -5.05 6.79 0.09 
10/4/2016 23 Lean 22.36 19.99 34.83 6.75 
10/4/2016 24 Lean 52.98 22.69 13.82 18.46 
10/4/2016 25 Lean -23.18 123.44 77.14 53.74 
10/4/2016 26 Lean to Ob 20.37 -94.85 26.40 -11.28 
10/4/2016 27 Lean to Ob 35.79 4.39 0.21 -2.06 
10/4/2016 28 Lean to Ob 55.00 23.32 0.85 -0.57 
10/4/2016 29 Lean to Ob* 647.02 1931.79 987.42 66.89 
10/4/2016 30 Lean to Ob* 56.29 -30.46 -91.39 -47.68 
10/4/2016 31 Obese -81.27 -160.11 -23.08 -11.89 
10/4/2016 32 Obese -87.18 -32.91 -34.19 -59.62 
10/4/2016 33 Obese* 18.44 -4.12 7.32 0.15 
10/4/2016 34 Obese* -251.90 33.81 -14.76 -3.33 
10/4/2016 35 Obese* -91.30 -1.74 -26.96 -0.87 
10/4/2016 36 Ob to Lean* -603.48 -205.22 -184.35 -113.04 
10/4/2016 37 Ob to Lean -72.73 -12.38 131.14 -26.31 
10/4/2016 38 Ob to Lean -22.89 -18.76 -18.50 12.19 
10/4/2016 39 Ob to Lean* -480.36 -109.64 -150.36 5.00 
10/4/2016 40 Ob to Lean* -191.79 -143.21 -132.14 -122.50 
* — indicates the data values that are outliers and to be excluded from the test for significance 
described below. 
Table 2. Mouse data from trial 2 with mouse IDs, weight type, and percent cytotoxicity at 
each of the four effector-to-target cell ratios obtained on December 20, 2016 
 % Cytotoxicity 
Date Mouse # Type 50:1 25:1 12.5:1 6.25:1 
12/20/2016 1 Lean 17.16 -6.21 -2.24 -6.90 
12/20/2016 2 Obese 2.93 -5.43 -11.12 -5.17 
12/20/2016 3 Ob to Lean 18.02 -11.12 -4.83 -10.26 
 
 The data from trial 1 and trial 2 were combined and outliers were removed using two 
methods. I first removed the outliers using the IQR rule. I also removed visual outliers that were 
unreliable by looking at the absorbance value readings that showed data that did not make 
practical sense. For example, some results from the plate readings showed maximum release of 
LDH in the YAC-1 cells lower than spontaneous release of LDH in the same concentration of 
YAC-1 cells. After removing these values, Table 3 shows the fifteen data points that remained 
and would be used in the statistical test. 
Table 3. Data from trial 1 and 2 combined with outliers removed. This was the final data 
set used in the tests for significance. 
 % Cytotoxicity 
Date Mouse # Type 100:1 50:1 25:1 12.5:1 
10/4/2016 21 Lean 5.66 12.45 18.28 2.87 
10/4/2016 22 Lean 12.36 -5.05 6.79 0.09 
10/4/2016 23 Lean 22.36 19.99 34.83 6.75 
10/4/2016 24 Lean 52.98 22.69 13.82 18.46 
10/4/2016 25 Lean -23.18 123.44 77.14 53.74 
10/4/2016 26 Lean to Ob 20.37 -94.85 26.40 -11.28 
10/4/2016 27 Lean to Ob 35.79 4.39 0.21 -2.06 
10/4/2016 28 Lean to Ob 55.00 23.32 0.85 -0.57 
10/4/2016 31 Obese -81.27 -160.11 -23.08 -11.89 
10/4/2016 32 Obese -87.18 -32.91 -34.19 -59.62 
10/4/2016 37 Ob to Lean -72.73 -12.38 131.14 -26.31 
10/4/2016 38 Ob to Lean -22.89 -18.76 -18.50 12.19 
12/20/2016 1 Lean - 17.16 -6.21 -2.24 
12/20/2016 2 Obese - 2.93 -5.43 -11.12 
12/20/2016 3 Ob to Lean - 18.02 -11.12 -4.83 
 
The ANOVA statistical test was run and the analysis is displayed below. Figure 2 shows percent 
cytotoxicity of the NK cells versus the four mouse weight types for all the effector-to-target cell 
ratios. At a p-value of 0.05, the only set of data that was significant was the 100:1 ratio which 
had a p-value of 0.0021. Figure 3 shows the statistically significant graph of 100:1 effector-to-
target cell ratio in greater detail. 
 
  
Figure 2. NK cell cytotoxicity for all 4 effector-to-target cell ratios and separated by weight 
type. 
Although the 50:1, 25:1, and 12.5:1 cell ratios were not statistically significant it is worth noting 
the general downward trend of the graphs as you go from lean, lean-to-obese, obese, and finally 
to obese-to-lean. 
  
Figure 3. NK cell cytotoxicity for the 100:1 spleen-to-cancer cell ratio. The p-value is less 
than 0.05 indicating statistical significance.  
The 100:1 effector-to-target cell ratio figure shows that there was a significant difference 
between the four mouse weight types in their NK cell cytotoxicity. Additionally, we can see that 
the lean and the lean-to-obese mice had greater cytotoxicity than the obese and obese-to-lean 
mice. To further explore this trend, I combined the lean and lean-to-obese mice in a group called 
“Lean Original” and the obese and obese-to-lean mice in a group called “Obese Original”. I ran a 
t-test to determine if there was a significant difference between these two groups when combined 
in a group with mice of the same original weight status. Figure 4 below shows percent 
cytotoxicity of the NK cells versus the two combined original mouse weight types for all the 
effector-to-target cell ratios. 
Figure 4. NK cell cytotoxicity for all 4 spleen-to-cancer cell ratios and separated by weight 
type. The weight types are combined into two groups with “Lean Original” and “Obese 
Original”. 
Similarly, with a p-value of 0.05 the only set of data that was significant was the 100:1 effector-
to-target cell ratio. Figure 5 shows the 100:1 effector-to-target cell ratio by itself because it was 
the only statistically significant data set. 
 
Figure 5. NK cell cytotoxicity for the 100:1 spleen-to-cancer cell ratio with the combined 
weight types. The p-value is less than 0.05 indicating statistical significance. 
This figure shows that there is a significant difference in the cytotoxicity of the mice based on 
their original weight status at the start of the experiment. Mice that were originally lean had more 
cytotoxic NK cell activity compared to the mice that were originally obese regardless of the 
weight status change they underwent. 
Discussion 
 Previous studies have established that the immune response to influenza vaccination is 
compromised in obese individuals. These studies also showed that NK cell cytotoxicity and 
enumeration were also decreased in the obese mice compared to lean mice (2). In this 
experiment, we wanted to expand on the study and attempt to establish an association similar to 
that described if there were weight changes in the mice. On top of the two groups of obese and 
lean mice, two additional groups were added to the study population to determine the effect of 
weight change on the immune response, specifically in NK cells. Four groups of mice were 
tested: always lean, lean-to-obese, obese-to-lean, and always obese. Because the original study 
had already established that always obese mice had decreased NK cell cytotoxicity and 
enumeration compared to the lean mice, I hypothesized that the obese-to-lean and the lean-to-
obese groups would have greater NK cell cytotoxicity than the always obese mice, but less than 
the always lean mice. Similarly, I also hypothesized that the obese-to-lean mice would have 
greater NK cell cytotoxicity than the lean-to-obese mice. I hypothesized this because I assumed 
that the metabolic changes that follow obesity would have a negative impact on NK cell 
production and effectiveness and therefore make the mice that became obese have a lower NK 
cell cytotoxicity than the mice that became lean. 
 Upon interpreting the data, we can make the conclusion that the hypothesis was incorrect. 
Looking at the percent cytotoxicity of the four groups at the different effector-to-target cell ratios 
from Figure 2, we can see a general downward trend. The lean and lean-to-obese mice generally 
tend to have greater NK cell percent cytotoxicity than the obese and obese-to-lean mice. This 
correlation hints at the idea that the lean and lean-to-obese mice were similar in their NK cell 
effectiveness and had greater cytotoxicity than obese and obese-to-lean groups. With a p-value of 
0.05, the only set of data that was significant was the 100:1 spleen-to-cancer cell ratio. For that 
particular set of data, we can say the difference between the four groups NK cell percent 
cytotoxicity was statistically significant. This is different from my hypothesis because it shows 
that mice that were lean-to-obese had better percent cytotoxicity than the obese-to-lean whereas I 
had predicted that the opposite.  
 To further investigate this claim, I combined both the lean and lean-to-obese mice in one 
group as “Lean Original” meaning that these were mice that had lean weight statuses at the start 
of the study period. I combined the obese and obese-to-lean groups in a second group called 
“Obese Original” for similar reasons. I ran the ANOVA test again and the results were seen in 
Figure 4. Figure 4 showed a similar trend to that in Figure 2, with the lean mice groups have 
higher percent cytotoxicity than the obese groups. At a p-value of 0.05, the only data set again 
that was statistically significant was the 100:1 spleen-to-cancer cell ratios. It is worth noting that 
the 12.5:1 data set had a p-value of 0.052 which was close to the acceptable p-value, but not 
statistically significant. Analyzing the 100:1 cell ratio graph in Figure 5 in more depth, we see 
that the mice that were originally lean at the start of the study had significantly higher NK cell 
percent cytotoxicity than the mice that were originally obese at the start of the study period. This 
analysis shows that mice starting out lean had a more effective NK cells than the mice that 
started out obese regardless of the weight status change that they underwent. There could be a 
few possible reasons as to why the results were as shown. 
 Epigenetics, such as DNA methylation and histone acetylation, are heritable components 
in DNA that do not change the underlying genetic code, but can play a role in gene expression. 
Environmental factors and nutrition can play a role in these epigenetic factors and therefore 
could potentially result in altered gene expression. As we discussed earlier, NK cells rely on an 
array of cell surface receptors and signaling mechanisms to detect and initiate interactions with 
virus-infected and cancer cells. One study found that KIR, an Ig-like receptor on NK cells which 
is one of the many receptors involved in a recognition mechanism to target cells is controlled by 
DNA methylation of the surrounding CpG islands of the KIR gene. Increased methylation 
resulted in decreased gene expression of this crucial surface receptor needed for NK cell 
functioning (14). On a similar note, a separate study looked at how obesity was associated with 
increased methylation of the LY86 gene. The LY86 is a lymphocyte antigen gene important for 
cell surface receptors of many immune cells showing the potential for DNA methylation to be a 
contributor to the altered NK cell response we saw in the study (15).  
 Another possible explanation for the results seen in this study may be due to NK cell 
turnover rate. A study looked at the dynamics and kinetics of splenic NK cell populations in 
different conditions. They concluded that “most splenic NK cells in adults are not dividing 
rapidly” and of the NK cell proliferation they do see, it is a small subset population of the entire 
NK cell population and the divisions are infrequent (16). Further inquiry into specific NK cell 
populations would be needed to be done before assumptions can be made about NK cell 
cytotoxicity. Determining whether NK cells would even proliferate and be effected by the 
metabolic changes occurring during the weight change would be a key focal point. However, as 
of now it seems that the NK cell populations generally remained constant throughout the weight 
change which is why the results showed that the original weight status of the mice was indicative 
of the NK cell cytotoxicity. 
Future Applications and Possible Limitations 
 The future applications of this study could be very beneficial in a society which is 
suffering from the harmful effects of the growing obesity epidemic. Knowing that immune 
response is suppressed in obese influenza-infected mice is useful, but having no solution is 
problematic. By exploring the topic of weight change on influenza-infected mice, we are 
attempting to determine if healthy lifestyle changes in order to induce weight change would be 
helpful in returning immune function. From a public health and preventative medicine 
standpoint, this is an important topic because it would allow for concrete evidence in inducing 
these weight changes to restore immune functionality, specifically NK cells. From the data 
gathered thus far, it does not seem like weight change has an effect on NK cell function, but 
further research is required to extensively research the intricacies of NK cells and their function 
in our immune systems. 
 There are some limitations to this study that should be considered when revising and 
repeating the study design. One would be to increase sample size. Because of the schedule and 
timing of mice being euthanized, I was only able to utilize about 23 samples for my study and 
then those only had 15 samples after removing outliers. Additionally, the NK cell population for 
this study was obtained from spleen tissue harvested from the mice. In a follow-up study, I 
would use NK cell populations from multiple sources such as lung and blood. There is literature 
which indicates that lung tissue in influenza-infected mice actually has separate NK cell 
populations than the other parts of the body. This could mean that different tissues have varying 
NK cell function and enumeration and could be an interesting area of study especially dealing 
with the influenza-infected models (17). On a similar note, the NK cells were not isolated from 
the spleenocytes which could have led to possible unwanted interactions/secretions within the 
spleenocytes that could manifest in the assay and alter readings. Spleenocytes consist of T-cells, 
B-cells, and other immune cells that potentially secrete cytokines and other signalers which can 
have an effect on NK cell function. By isolating the NK cells from the tissues, it would ensure 
that only the NK cells and the target (YAC-1) cells would be interacting. Additionally, studies 
have shown the NK cells have two types of cytolytic activity, spontaneous and induced. 
Spontaneous is the baseline cytoxic ability of the NK cell population whereas the induced is the 
additional NK cell cytotoxic ability that comes from inducers such as interferon gamma which 
activates NK cell activity. Developing a study with and without these inducers may allow us to 
study the full potential of NK cell cytotoxicity. Finally, I would increase the study duration to 
allow for the NK cell populations to proliferate under the new metabolic conditions of the mice. 
The study cited earlier discussed splenic NK cell turnover rate and infrequent subpopulation 
divisions (16). Allowing more time for the NK cell populations to adjust to the new metabolic 
status may give us insight in a follow-up study into how the NK cell population adjusts over 
time.  
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